BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 21111641)

  • 1. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
    Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
    Kumar S; Bhavana K; Kumar S; Kumar P
    J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
    Ali H; Saleh M; Mohammed W
    Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy in venous malformation.
    Rabe E; Pannier F
    Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous malformations with sclerosant in microfoam form.
    Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
    Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
    Jain R; Bandhu S; Sawhney S; Mittal R
    J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
    Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
    Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for using radiopaque sclerosing foam to treat venous malformations.
    Li K; Liu YR; Chen AW; Liu SH
    Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study.
    Leal BAN; Procópio RJ; Dardik A; Navarro TP
    Ann Vasc Surg; 2023 Feb; 89():68-77. PubMed ID: 37466046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy of face and oral cavity low flow vascular malformations: our experience.
    Górriz-Gómez E; Vicente-Barrero M; Loras-Caballero ML; Bocanegra-Pérez S; Castellano-Navarro JM; Pérez-Plasencia D; Ramos-Macías A
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):43-7. PubMed ID: 23660343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis.
    Gao Z; Zhang Y; Li W; Shi C
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29082587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
    Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
    Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of foam sclerotherapy for the treatment of oropharyngeal venous malformation].
    Niu CQ; Jiang H; Zhou SY; Shen G; Li HB; Zhang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Mar; 53(3):209-213. PubMed ID: 29614554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.